Preclinical studies with 5,10,15-tris(4-methylpyridinium)-20-phenyl-[21H, 23H]-porphine trichloride for the photodynamic treatment of superficial mycoses caused by trichophyton rubrum

Photochemistry and Photobiology

Volumn 85, Issue 3, 2009, Pages 733-739

  Smijs, Threes G M ^a   Pavel, Stan ^a   Talebi, Mojgan ^a   Bouwstra, Joke A ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

5,10,15 TRIS(4 METHYLPYRIDINIUM) 20 PHENYL (21H,23H) PORPHINE; 5,10,15-TRIS(4-METHYLPYRIDINIUM)-20-PHENYL-(21H,23H)-PORPHINE; PORPHYRIN; PYRIDINIUM DERIVATIVE;

ARTICLE; HUMAN; MICROBIOLOGY; MYCOSIS; PATHOGENICITY; PH; PHOTOCHEMOTHERAPY; TRICHOPHYTON;

HUMANS; HYDROGEN-ION CONCENTRATION; MYCOSES; PHOTOCHEMOTHERAPY; PORPHYRINS; PYRIDINIUM COMPOUNDS; TRICHOPHYTON;

ARTHRODERMATACEAE; FUNGI; TRICHOPHYTON RUBRUM;

EID: 65349083737     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-1097.2008.00468.x     Document Type: Article

References (44)

1. Elewski, B. E. P. G. Hazen (1989) The superficial mycoses and the dermatophytes. J. Am. Acad. Dermatol. 21, 655 673.
2. Wagner, D. K. P. G. Sohnle (1995) Cutaneous defenses against dermatophytes and yeasts. Clin. Microbiol. Rev. 8, 317 335.
3. Hainer, B. L. (2003) Dermatophyte infections. Am. Fam. Physician 67, 101 108.
4. Borgers, M., H. Degreef G. Cauwenbergh (2005) Fungal infections of the skin: Infection process and antimycotic therapy. Curr. Drug Targets. 6, 849 862.
5. Weitzman, I. R. C. Summerbell (1995) The dermatophytes. Clin. Microbiol. Rev. 8, 240 259.
6. Duek, L., G. Kaufman, Y. Ulman I. Berdicevsky (2004) The pathogenesis of dermatophyte infections in human skin sections. J. Infect. 48, 175 180.
7. Graser, Y., S. De Hoog R. C. Summerbell (2006) Dermatophytes: Recognizing species of clonal fungi. Med. Mycol. 44, 199 209.
8. Aly, R. (1994) Ecology and epidemiology of dermatophyte infections. J. Am. Acad. Dermatol. 31, S21 S25.
9. Djeridane, A., Y. Djeridane A. Ammar-Khodja (2006) Epidemiological and aetiological study on tinea pedis and onychomycosis in Algeria. Mycoses 49, 190 196.
10. Finlay, A. Y. (1994) Global overview of Lamisil. Br. J. Dermatol. 130 (Suppl. 43 1 3.
11. Vera, J. R. L. A. Cervera (2001) Advantages and disadvantages of topical antifungal agents. Rev. Esp. Quimioter. 14, 232 237.
12. Hay, R. J. (1993) Therapy. In Fungi and Skin Disease, pp. 67 82. Wolfe Publishing, London.
13. Gupta, A. K., T. R. Einarson, R. C. Summerbell N. H. Shear (1998) An overview of topical antifungal therapy in dermatomycoses. A North American perspective. Drugs 55, 645 674.
14. Evans, E. G. (2001) The rationale for combination therapy. Br. J. Dermatol. 145 (Suppl. 60 9 13.
15. Kyle, A. A. M. V. Dahl (2004) Topical therapy for fungal infections. Am. J. Clin. Dermatol. 5, 443 451.
16. Dahl, M. V. (1993) Suppression of immunity and inflammation by products produced by dermatophytes. J. Am. Acad. Dermatol. 28, S19 S23.
17. Calzavara-Pinton, P. G., M. Venturini R. Sala (2005) A comprehensive overview of photodynamic therapy in the treatment of superficial fungal infections of the skin. J. Photochem. Photobiol. B 78, 1 6.
18. Zeina, B., J. Greenman, W. M. Purcell B. Das (2001) Killing of cutaneous microbial species by photodynamic therapy. Br. J. Dermatol. 144, 274 278.
19. Hamblin, M. R. T. Hasan (2004) Photodynamic therapy: A new antimicrobial approach to infectious disease? Photochem. Photobiol. Sci. 3, 436 450.
20. Demidova, T. N. M. R. Hamblin (2004) Photodynamic therapy targeted to pathogens. Int. J. Immunopathol. Pharmacol. 17, 245 254.
21. Smijs, T. G., J. A. Bouwstra, H. J. Schuitmaker, M. Talebi S. Pavel (2007) A novel ex vivo skin model to study the susceptibility of the dermatophyte Trichophyton rubrum to photodynamic treatment in different growth phases. J. Antimicrob. Chemother. 59, 433 440.
22. Smijs, T. G., J. A. Bouwstra, M. Talebi S. Pavel (2007) Investigation of conditions involved in the susceptibility of the dermatophyte Trichophyton rubrum to photodynamic treatment. J. Antimicrob. Chemother. 60, 750 759.
23. Nielsen, J. B. (2005) Percutaneous penetration through slightly damaged skin. Arch. Dermatol. Res. 296, 560 567.
24. Polderman, M. C., S. Pavel, B. J. Vermeer M. Wintzen (1999) Ultraviolet A-I phototherapy for skin diseases. Ned. Tijdschr. Geneeskd. 143, 931 934.
25. Polderman, M. C., S. le Cessie, T. W. Huizinga S. Pavel (2004) Efficacy of UVA-1 cold light as an adjuvant therapy for systemic lupus erythematosus. Rheumatology (Oxford) 43, 1402 1404.
26. Polderman, M. C., M. Wintzen, S. le Cessie S. Pavel (2005) UVA-1 cold light therapy in the treatment of atopic dermatitis: 61 Patients treated in the Leiden University Medical Center. Photodermatol. Photoimmunol. Photomed. 21, 93 96.
27. Zurita, J. R. J. Hay (1987) Adherence of dermatophyte microconidia and arthroconidia to human keratinocytes in vitro. J. Invest. Dermatol. 89, 529 534.
28. Thomsen, V., D. Schatzlein D. Mercuro (2003) Limits of detection in spectroscopy. Spectroscopy 18, 112 114.
29. Smijs, T. G., A. A. Mulder, S. Pavel, J. J. Onderwater, H. K. Koerten J. A. Bouwstra (2008) Morphological changes of the dermatophyte Trichophyton rubrum after photodynamic treatment: A scanning electron microscopy study. Med. Mycol. 46, 315 325.
30. Plasencia-Gil, M. I., L. Norlen L. A. Bagatolli (2007) Direct visualization of lipid domains in human skin stratum corneum's lipid membranes: Effect of pH and temperature. Biophys. J. 93 (9 3142 3155.
31. Bouwstra, J. A. M. Ponec (2006) The skin barrier in healthy and diseased state. Biochim. Biophys. Acta 1758, 2080 2095.
32. Hatziantoniou, S., M. Rallis, C. Demetzos G. T. Papaioannou (2000) Pharmacological activity of natural lipids on a skin barrier disruption model. Pharmacol. Res. 42, 55 59.
33. Godwin, D. A. B. B. Michniak (1999) Influence of drug lipophilicity on terpenes as transdermal penetration enhancers. Drug Dev. Ind. Pharm. 25, 905 915.
34. Green, P. G., J. Hadgraft G. Ridout (1989) Enhanced in vitro skin permeation of cationic drugs. Pharm. Res. 6, 628 632.
35. Ridout, G., J. Houk, R. H. Guy, G. C. Santus, J. Hadgraft L. L. Hall (1992) An evaluation of structure-penetration relationships in percutaneous absorption. Farmaco 47, 869 892.
36. Romagnoli, C., D. Mares, G. Sacchetti A. Bruni (1998) The photodynamic effect of 5-(4-hydroxy-1-butinyl)-2,2-bithienyl on dermatophytes. Mycol. Res. 102, 1519 1524.
37. Moretti, M. B., S. C. Garcia A. Batlle (2000) Porphyrin biosynthesis intermediates are not regulating delta-aminolevulinic acid transport in Saccharomyces cerevisiae. Biochem. Biophys. Res. Commun. 272, 946 950.
38. Strakhovskaya, M. G., A. O. Shumarina, G. Y. Fraikin A. B. Rubin (1999) Endogenous porphyrin accumulation and photosensitization in the yeast Saccharomyces cerevisiae in the presence of 2,2′-dipyridyl. J. Photochem. Photobiol. B 49, 18 22.
39. Strakhovskaya, M. G., A. O. Shumarina, G. Y. Fraikin A. B. Rubin (1998) Synthesis of protoporphyrin IX induced by 5-aminolevulinic acid in yeast cells in the presence of 2,2′-dipyridyl. Biochemistry (Mosc.) 63, 725 728.
40. de Gruijl, F. R., H. J. Sterenborg, P. D. Forbes, R. E. Davies, C. Cole, G. Kelfkens, H. van Weelden, H. Slaper J. C. van der Leun (1993) Wavelength dependence of skin cancer induction by ultraviolet irradiation of albino hairless mice. Cancer Res. 53, 53 60.
41. Setlow, R. B., E. Grist, K. Thompson A. D. Woodhead (1993) Wavelengths effective in induction of malignant melanoma. Proc. Natl Acad. Sci. USA 90, 6666 6670.
42. Seite, S., D. Moyal, M. P. Verdier, C. Hourseau A. Fourtanier (2000) Accumulated p53 protein and UVA protection level of sunscreens. Photodermatol. Photoimmunol. Photomed. 16, 3 9.
43. Pavel, S. (2006) Light therapy (with UVA-1) for SLE patients: Is it a good or bad idea? Rheumatology (Oxford) 45, 653 655.
44. Deacon, J. W. (2006) The moulds of man. In Fungal Biology (Edited by M. D. Morecroft J. I. L. Morison pp. 322 337. Blackwell Publishing Ltd, Oxford.